Oral cyclosporine but not tacrolimus reduces renal transplant blood flow

Transplantation

Volumn 77, Issue 9 SUPPL., 2004, Pages 1457-1459

  Nankivell, Brian J ^a,b   Chapman, Jeremy R ^a   Bonovas, George ^a   Gruenewald, Simon M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; FEMALE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY VASCULAR RESISTANCE; MALE; MICROEMULSION; NEPHROTOXICITY; PRIORITY JOURNAL; RENAL ARTERY; VASOCONSTRICTION;

ADMINISTRATION, ORAL; ADULT; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL ARTERY; RENAL CIRCULATION; TACROLIMUS;

EID: 2442645079     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000121196.71904.E0     Document Type: Article

References (10)

1. McNally PG, Feehally J. Pathophysiology of cyclosporine A nephrotoxicity: Experimental and clinical observations. Nephrol Dial Transplant 1992; 7: 791.
2. Perico N, Ruggenenti P, Gaspari F, et al. Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 1992; 54: 56.
3. Nankivell BJ, Chapman JR, Gruenewald S. Detection of chronic allograft nephropathy by quantitative Doppler imaging. Transplantation 2002; 74: 90.
4. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
5. Tublin ME, Bude RO, Platt JF. The resistive index in renal Doppler sonography: Where do we stand? Am J Radiology 2003; 180: 885.
6. Venkat-Raman G, Feehally J, Elliot HL, et al. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients. Nephrol Dial Transplant 1998; 13; 2612.
7. Ruggenenti P, Perico N, Mosconi L, et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993; 43: 706.
8. Benigni A, Morigni M, Perico N, et al. The acute effect of FK 506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 1992; 54: 775.
9. Radermacher J, Meiners M, Bramlage C, et al. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506. Transpl Int 1998; 11: 3.
10. Klein IHHT, Abrahams A, van Ede T, et al. Different effects of Tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. Transplantation 2002; 73: 732.